Cervical Neuroendocrine Cancer — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Neuroendocrine cervical cancer is aggressive, managed similarly to small cell carcinoma with platinum-etoposide chemotherapy ± radiation
Neuroendocrine carcinoma of the cervix (small cell/large cell type) is rare (<5% of cervical cancers) but highly aggressive with a propensity for early distant metastasis. Management follows small cell carcinoma principles: platinum-etoposide chemotherapy with concurrent radiation for localised disease, and systemic chemotherapy for metastatic disease. Prognosis is significantly worse than squamous or adenocarcinoma histology. Standard cervical cancer staging and treatment paradigms (chemoradiation alone) are inadequate.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cancer